Li T - Search Results

1

Serum microRNA panel for early diagnosis of the onset of hepatocellular carcinoma.

Zhang Y, Li T, Qiu Y, Zhang T, Guo P, Ma X, Wei Q, Han L. Zhang Y, et al. Among authors: li t. Medicine (Baltimore). 2017 Jan;96(2):e5642. doi: 10.1097/MD.0000000000005642. Medicine (Baltimore). 2017. PMID: 28079796 Free PMC article.

2

A Simple Noninvasive Index Can Predict Hepatocellular Carcinoma in Patients with Chronic Hepatitis B.

Zhu L, Li T, Ma X, Qiu Y, Ma X, Lin Y, Han L, Qin C. Zhu L, et al. Among authors: li t. Sci Rep. 2017 Aug 21;7(1):8954. doi: 10.1038/s41598-017-09358-z. Sci Rep. 2017. PMID: 28827721 Free PMC article.

3

VEGFR-1 activation-induced MMP-9-dependent invasion in hepatocellular carcinoma.

Li T, Zhu Y, Han L, Ren W, Liu H, Qin C. Li T, et al. Future Oncol. 2015;11(23):3143-57. doi: 10.2217/fon.15.263. Epub 2015 Nov 9. Future Oncol. 2015. PMID: 26551737 Free PMC article.

4

Loss of AIM2 expression promotes hepatocarcinoma progression through activation of mTOR-S6K1 pathway.

Ma X, Guo P, Qiu Y, Mu K, Zhu L, Zhao W, Li T, Han L. Ma X, et al. Among authors: li t. Oncotarget. 2016 Jun 14;7(24):36185-36197. doi: 10.18632/oncotarget.9154. Oncotarget. 2016. PMID: 27167192 Free PMC article.

5

Tripartite motif 31 promotes resistance to anoikis of hepatocarcinoma cells through regulation of p53-AMPK axis.

Guo P, Qiu Y, Ma X, Li T, Ma X, Zhu L, Lin Y, Han L. Guo P, et al. Among authors: li t. Exp Cell Res. 2018 Jul 1;368(1):59-66. doi: 10.1016/j.yexcr.2018.04.013. Epub 2018 Apr 14. Exp Cell Res. 2018. PMID: 29665353

6

The E3 ubiquitin ligase TRIM7 suppressed hepatocellular carcinoma progression by directly targeting Src protein.

Zhu L, Qin C, Li T, Ma X, Qiu Y, Lin Y, Ma D, Qin Z, Sun C, Shen X, Zhao Y, Han L. Zhu L, et al. Among authors: li t. Cell Death Differ. 2020 Jun;27(6):1819-1831. doi: 10.1038/s41418-019-0464-9. Epub 2019 Dec 4. Cell Death Differ. 2020. PMID: 31802035 Free PMC article.

7

NOD1 inhibits proliferation and enhances response to chemotherapy via suppressing SRC-MAPK pathway in hepatocellular carcinoma.

Ma X, Qiu Y, Zhu L, Zhao Y, Lin Y, Ma D, Qin Z, Sun C, Shen X, Li T, Han L. Ma X, et al. Among authors: li t. J Mol Med (Berl). 2020 Feb;98(2):221-232. doi: 10.1007/s00109-019-01868-9. Epub 2019 Dec 23. J Mol Med (Berl). 2020. PMID: 31872284

8

NOD2 inhibits tumorigenesis and increases chemosensitivity of hepatocellular carcinoma by targeting AMPK pathway.

Ma X, Qiu Y, Sun Y, Zhu L, Zhao Y, Li T, Lin Y, Ma D, Qin Z, Sun C, Han L. Ma X, et al. Among authors: li t. Cell Death Dis. 2020 Mar 6;11(3):174. doi: 10.1038/s41419-020-2368-5. Cell Death Dis. 2020. PMID: 32144252 Free PMC article.

9

Inhibiting Src-mediated PARP1 tyrosine phosphorylation confers synthetic lethality to PARP1 inhibition in HCC.

Sun C, Jing W, Xiong G, Ma D, Lin Y, Lv X, Zhao Y, Ma X, Zhu L, Shen X, Yang M, Qin Z, Cheng Y, Xuan H, Li T, Han L. Sun C, et al. Among authors: li t. Cancer Lett. 2022 Feb 1;526:180-192. doi: 10.1016/j.canlet.2021.11.005. Epub 2021 Nov 8. Cancer Lett. 2022. PMID: 34762994

10

Deregulation of the NLRP3 inflammasome in hepatic parenchymal cells during liver cancer progression.

Wei Q, Mu K, Li T, Zhang Y, Yang Z, Jia X, Zhao W, Huai W, Guo P, Han L. Wei Q, et al. Among authors: li t. Lab Invest. 2014 Jan;94(1):52-62. doi: 10.1038/labinvest.2013.126. Epub 2013 Oct 28. Lab Invest. 2014. PMID: 24166187 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40,069 results

Search Page

Filters